ReviewCureus2025
Anatomical Insights into Gamma Knife Radiosurgery: Exploring Efficacy Across Infratentorial and Supratentorial Meningiomas.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gamma Knife radiosurgery (GKRS) is a well-established, minimally invasive treatment modality for meningiomas, offering high rates of tumor control and symptom relief. However, clinical outcomes are influenced by tumor anatomical location, necessitating a comprehensive evaluation of its effectiveness across infratentorial and supratentorial regions. A systematic review was conducted by following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, including clinical trials and observational studies evaluating GKRS outcomes in meningiomas. Studies were included if they explicitly stratified results by anatomical location and reported clinical outcomes such as tumor control, progression-free survival (PFS), symptom relief, and complications. The ROBINS-I (Risk of Bias in Non-randomized Studies - of Interventions) tool was used to assess the risk of bias. Data were synthesized qualitatively, and outcomes were compared between anatomical locations. Eighteen studies involving 2,257 patients were included. Overall five-year tumor control rates were high for both infratentorial (93.2%) and supratentorial (91.4%) meningiomas. Infratentorial tumors showed slightly better control rates but higher complication rates, including peritumoral edema and cranial nerve deficits due to proximity to critical structures. Supratentorial meningiomas demonstrated favorable long-term outcomes with fewer complications. Infratentorial tumors achieve excellent control but present higher risks of complications, partly due to their proximity to critical structures and the need for precise dosimetry in typically smaller tumors. In contrast, supratentorial tumors, often larger and more accessible, benefit from fewer adverse events and comparable long-term outcomes. Tumor size, along with anatomical location, plays a key role in radiosurgical planning and complication risk. Future research should focus on prospective studies to refine treatment protocols and enhance outcomes in atypical and anaplastic meningiomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.